| Symbol: | 
  	  
	  MARVELD2
	   | 
      
	  
      
  	  | Description: | 
  	  
	  
	  MARVEL domain containing 2 [Source:HGNC Symbol;Acc:26401]
	  
	   | 
      
      
  	  | Location: | 
  	  
	  Chr5:68710939-68740157[+]
	   | 
      
	  
         
	   
       | CRmiRSNP:
	   
		
	   ~ Export ~
	    
	    | 
      	
      	
      		Records:null
      		 
      			
      			
      				| Compound | 
					CRmiRSNP | 
					SNP_sig | 
					Model | 
					Molecule | 
					Mol_sig | 
					Type | 
      			 
      			
      			
      		 	
      		
      		
      			Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant 
				Total:0 Current:1 
      			[First] [Prev] [Next] [Last] 
      		 
      	 | 
      
	  
	  
	  
       | Compound:
	    
		
	    ~ Export ~
	   
		
	    | 
	  
      	
      	
      		Records:154			
      		 
      			
      				| Gene | 
					Compound | 
      				Gen_sig | 
					Exp_pattern | 
      			 
      		    
      			
      			
				    | MARVELD2 | 
					NSC 105348 | 
      				0.046 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					NSC 109834 | 
      				0.013 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- | 
      				0.04 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					NSC 168197 | 
      				0.024 | 
      				Down | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					9-METHOXYCAMPTOTHECIN | 
      				0.002 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					Hydrazinecarbothioamide, 2,2'-(1,5-dimethyl-1,5-pentanediylidene)bis[N-methyl- | 
      				0.028 | 
      				Down | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					4-Benzylidene-2-phenyl-5(4H)-oxazolone | 
      				0.005 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					NSC 295642 | 
      				0.025 | 
      				Down | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					AI 3-63984 | 
      				0.039 | 
      				Down | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					1-Piperazinecarboselenoic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide | 
      				0.027 | 
      				Down | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					CHALCONE ANALOG | 
      				0.019 | 
      				Down | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					NSC 351351 | 
      				0.009 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					NSC 36758 | 
      				0.028 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- | 
      				0.022 | 
      				Up | 
      			 
      				
      			
      			
				    | MARVELD2 | 
					ANTINEOPLASTIC-376265 | 
      				0.017 | 
      				Down | 
      			 
      					
      		 
			
			 Expression pattern: Sensitivity / Resistance 
      			Total:11 Current:1 
      			[First] [Prev]  Next Last 
      		  	
      	 | 
      
	   
	  
       | SNP:
	   
		
	    ~ Export ~
	   
	    | 
      	
      	
      		Records:2
      		 
      			
      			
      				| SNP | 
					Gene | 
					SNP_location | 
					SNP_allele | 
					
				 
      			
      			
      			
      				| rs142001621 | 
					MARVELD2 | 
					Chr5:68737747 | 
					T/A | 
      			 
      				
      			
      			
      				| rs192412701 | 
					MARVELD2 | 
					Chr5:68737815 | 
					C/T | 
      			 
      				
      		 	
			
      			Total:1 Current:1 
      			[First] [Prev] [Next] [Last] 
      		 		
      	 | 
      
	  
	  
	  
       | miRNA:
	   
		
	    ~ Export ~
	    
	    | 
      	
      	
      		Records:74
      		 
      			
      			
				    | Gene | 
					Gen_transcript | 
      				miRNA | 					
					miR_location | 
					
					
      			 
				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-593-5p | 
					Chr7:127721928-127721952[+] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-597 | 
					Chr8:9599197-9599218[+] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-599 | 
					Chr8:100548879-100548898[-] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-606 | 
					Chr10:77312276-77312296[+] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-614 | 
					Chr12:13068816-13068838[+] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-621 | 
					Chr13:41384962-41384982[+] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-636 | 
					Chr17:74732548-74732570[-] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-654-3p | 
					Chr14:101506606-101506627[+] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-661 | 
					Chr8:145019374-145019397[-] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-663a | 
					Chr20:26188879-26188900[-] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-875-3p | 
					Chr8:100549025-100549045[-] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-885-3p | 
					Chr3:10436183-10436204[-] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-887 | 
					Chr5:15935338-15935359[+] | 
      			 
      				
      			
      			
      				| MARVELD2 | 
					ENST00000325631 | 
					hsa-mir-892a | 
					ChrX:145078197-145078217[-] | 
      			 
      				
      		 
					
      	 |